Used as an intermediate in the synthesis of antimicrobial and antiparasitic agents. Shows potential in the development of drugs targeting anaerobic bacteria and certain protozoal infections due to its nitroimidazole core, which can interfere with microbial DNA synthesis. Investigated for use in treatments against pathogens resistant to conventional antibiotics. Also explored in research for antitubercular compounds owing to its heterocyclic structure with chlorine and nitro functional groups enhancing biological activity.